This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Miao Zhao: Innovator in Fungal Infection Treatment
Introduction
Miao Zhao is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of fungal infections. His innovative work has led to the development of compounds that address drug-resistant strains of fungi.
Latest Patents
Miao Zhao holds a patent for "Turbinmicin compounds, compositions and uses thereof." This patent includes the isolated compound of Formula (I) or IA, as well as Turbinomycin compounds of Formula (II) or (IIA). The patent describes a compound isolated from a bacterial species found in sea squirts, with a chemical formula of CHNO. The compositions disclosed include effective amounts of turbinmicin or turbinomicin compounds for treating fungal infections, including those that are drug-resistant. Methods of treating these infections using turbinmicin and its compounds are also detailed in the patent.
Career Highlights
Miao Zhao is associated with the Wisconsin Alumni Research Foundation, where he continues to advance research in his field. His work has garnered attention for its potential impact on public health, particularly in combating fungal infections that are resistant to conventional treatments.
Collaborations
Miao Zhao has collaborated with notable colleagues such as Timothy Bugni and Douglas Braun. Their combined expertise has contributed to the success of their research initiatives.
Conclusion
Miao Zhao's innovative contributions to the field of fungal infection treatment highlight the importance of research and development in addressing health challenges. His work exemplifies the potential of scientific advancements to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
